等待开盘 09-20 09:30:00 美东时间
+0.340
+5.18%
Analyst Kallum Titchmarsh of Morgan Stanley maintained a Hold rating on Sight S...
09-05 19:17
However, the Company expects Dry Eye revenue to decrease as it implements an increase in dry eye pricing effective October 1, 2024, which it believes will have a significant negative impact on cash-pay procedure volumes
08-02 05:10
Sight Sciences, Inc. (NASDAQ:SGHT) shares have continued their recent momentum ...
07-23 18:55
Sight Sciences, Inc. (NASDAQ:SGHT) insiders who purchased shares in the last 12...
07-12 20:43
Gainers: Cue Health (HLTH) +142%. OneMedNet (ONMD) +54%. Gain Therapeutics (GANX) +18%. Canopy Growth (CGC) +13%. Alignment Healthcare (ALHC) +13%. Losers: Biosig Technologies (BSGM) -18%. Agilent Tec...
05-30 22:01
Sight Sciences (SGHT) has shared an update. Sight Sciences has released an inve...
05-03 04:25
Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) with a Hold.
04-10 17:24
Gainers: ARCA biopharma (ABIO) +91% to merge with Oruka Therapeutics in all-stock transaction. LAMF Global Ventures (LGVC) +85% approve business combination with Nuvo Group Helius Medical Technolog...
04-03 20:53
Gainers: Sight Sciences (SGHT) +19%. Zapata Computing Holdings (ZPTA) +9%. Cal-Maine Foods (CALM) +6%. Vanda Pharmaceuticals (VNDA) +5%. iHeartMedia (IHRT) +5%. Losers: Acorda Therapeutics (ACOR) -9...
04-03 04:43